/Investor DB

Food and Drug Administration (FDA) — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

BIOINFOEXPERTS LLCbioinfox.comin𝕏Sep 2023 · $295.9K

BioInfoExperts builds software and genetic analysis services to track pathogen spread and help infection control practitioners, state contact tracers, and healthcare organizations defend against disease outbreaks.

AI & Machine LearningBiotechDigital HealthAlachua, US

Susanna Lamers(Chief Executive Officer)Rebecca Rose(Chief Technical Officer)David J. Nolan(Laboratory Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.